Hepatic Steatosis and Alcoholic Hepatitis

  • Mark R. Versland
Part of the Current Clinical Practice book series (CCP)

Abstract

The liver normally contains lipid equal to approx 5% of its weight. These lipids are composed of triglycerides, phospholipids, cholesterol, and cholesterol esters. Hepatic steatosis, or fatty liver, results from excess accumulation of lipid, primarily triglycerides, but also phospholipids. It may be clinically insignificant or lead to development of cirrhosis.

Keywords

Obesity Pancreatitis Coumadin Folate Tamoxifen 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ginsberg HN. Lipoprotein metabolism and its relationship to atherosclerosis. Med Clin North Am 1994;78:1–20.PubMedGoogle Scholar
  2. 2.
    Gibbons GF. Assembly and secretion of hepatic very low density lipoprotein. Biochem J 1990;268:1–13.PubMedGoogle Scholar
  3. 3.
    Alpers DH, Sabesin SM, White HM. Fatty liver: biochemical and clinical aspects. In: Schiff L, Schiff ER, eds. Diseases of the liver. Lippincott, Philadelphia 1993; pp. 825–855.Google Scholar
  4. 4.
    Baraona E. Effects of ethanol on lipid metabolism. J Lipid Res 1979;20:289–315.PubMedGoogle Scholar
  5. 5.
    Sabesin SM. Accumulation of nascent lipoproteins in rat hepatic golgi during induction of fatty liver by orotic acid. Lab Invest 1977;37:127–135.PubMedGoogle Scholar
  6. 6.
    Lieber CS. Alcohol and the liver: 1994 update. Gastroenterology 1994; 106:1085–1105.PubMedGoogle Scholar
  7. 7.
    Rolfes DB. Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases. Hepatology 1985;5:1149–1158.PubMedCrossRefGoogle Scholar
  8. 8.
    Teli MR. The natural history of non-alcoholic fatty liver: A follow-up study. Hepatology 1995;22:1714–1719.PubMedCrossRefGoogle Scholar
  9. 9.
    Creutzfeldt W Liver disease and diabetes mellitus. Prog in Liver Dis 1970;3:371–407.Google Scholar
  10. 10.
    Sternlieb I. Mitochondrial and fatty changes in hepatocytes of patients with Wilson’s disease. Gastroenterology 1968;55:354–367.PubMedGoogle Scholar
  11. 11.
    Waterlow JC. Protein malnutrition in children: advances in knowledge in the past 10 years. Adv Protein Chem 1971;25:117–241.PubMedCrossRefGoogle Scholar
  12. 12.
    Adibi SA. Perspectives on gastrointestinal surgery for treatment of morbid obesity: the lesson learned. Gastroenterology 1984;87:1381–1391.PubMedGoogle Scholar
  13. 13.
    Jeejeebhoy KN. Total parenteral nutrition at home: studies in patients surviving four months to five years. Gastroenterology 1976;71:943–953.PubMedGoogle Scholar
  14. 14.
    Jeanrenaud B. Effect of glucocorticoid hormone on fatty acid mobilization and re-esterification in rat adipose tissue. Biochem J 1967; 103:627–633.PubMedGoogle Scholar
  15. 15.
    Lewis JH. Methotrexate-induced chronic liver injury: guidelines for detection and prevention. Am J Gastro 1988;88:1337–1345.Google Scholar
  16. 16.
    Zimmerman HJ. Valproate-induced hepatic injury: analysis of 23 fatal cases. Hepatology 1982;2:591–597.PubMedCrossRefGoogle Scholar
  17. 17.
    Combes B. Tetracycline and the liver. Prog Liver Dis 1972;4:589–596.PubMedGoogle Scholar
  18. 18.
    Guigui B. Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease. Hepatology 1988;8:1063–1068.PubMedCrossRefGoogle Scholar
  19. 19.
    Scheuer P. The pathology of hepatitis C. Hepatology 1992;15:567–571.PubMedCrossRefGoogle Scholar
  20. 20.
    Peters LJ. Reye’s syndrome in adults. A case report and review of the literature. Arch Int Med 1986;146:2401–2403.CrossRefGoogle Scholar
  21. 21.
    Schneiderman DJ. Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS). Hepatology 1987;7:925–930.PubMedCrossRefGoogle Scholar
  22. 22.
    Bacon BR. Non-alcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103–1109.PubMedGoogle Scholar
  23. 23.
    Lee JKT. Fatty infiltration of the liver: demonstration by proton spectroscopic imaging. Radiology 1984;153:195–201.PubMedGoogle Scholar
  24. 24.
    Laurin J. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 1996;23:1464–1467.PubMedCrossRefGoogle Scholar
  25. 25.
    Mendenhall CL. Alcoholic hepatitis. In: Schiff L, Schiff ER, eds. Diseases of the liver. Lippincott, Philadelphia, 1993; pp. 856–874.Google Scholar
  26. 26.
    Peqiugnot G. Ascitic cirrhosis in relation to alcohol consumption. Int J Epidemiology 1978;7:113–120.CrossRefGoogle Scholar
  27. 27.
    Morgan MY, Sherlock S. Sex related differences among 100 patients with alcoholic liver disease. BMJ 1977;1:939–941.PubMedCrossRefGoogle Scholar
  28. 28.
    Haber PS. Metabolism of alcohol by human gastric cells: Relation to first-pass metabolism. Gastroenterology 1996;111:863–870.PubMedCrossRefGoogle Scholar
  29. 29.
    Lieber CS. Biochemical factors in alcoholic liver disease. Seminars in Liver Dis 1993;13:136–153.CrossRefGoogle Scholar
  30. 30.
    Pares A. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 1990;12:1295–1299.PubMedCrossRefGoogle Scholar
  31. 31.
    Mendenhall CL. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. Alcoholic hepatitis. Clin Gastroenterol 1981; 10:417–441.PubMedGoogle Scholar
  32. 32.
    Arron R. Molecular biological aspects of alcohol-induced liver disease. Alcoholism: Clin Exp Res 1995; 19:247–256.CrossRefGoogle Scholar
  33. 33.
    Goldberg SJ. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis IV: Describing the population with minimal hyperbilirubinemia. Am J Gastro 1986;11:1024–1037.Google Scholar
  34. 34.
    Mendenhall CL. Protein calorie malnutrition associated with alcoholic hepatitis: Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. Am J Med 1984;76:211–222.PubMedCrossRefGoogle Scholar
  35. 35.
    Garner WL. Cholescintigraphy in the critically ill. Am J Surg 1988;155:727–729.PubMedCrossRefGoogle Scholar
  36. 36.
    Shuman WP. PIPIDA scintigraphy for cholecystitis: false positives in alcoholism and total parenteral nutrition. Am J Radiol 1982;138:1–6.Google Scholar
  37. 37.
    Mezey E. Treatment of alcoholic liver disease. Sem Liver Dis 1993;13:210–216.CrossRefGoogle Scholar
  38. 38.
    Carithers RL. Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial. Ann Int Med 1989; 110:685–690.PubMedGoogle Scholar
  39. 39.
    Galambos JT. Alcoholic hepatitis: its therapy and prognosis. Prog Liver Dis 1972;4:567–588.PubMedGoogle Scholar
  40. 40.
    Orrego H. Long-term treatment of alcoholic liver disease with propylthiouracil. NEJM 1987;317:1421–1427.PubMedCrossRefGoogle Scholar
  41. 41.
    Morgan TR. Treatment of alcoholic hepatitis. Sem Liver Dis 1993; 13:384–394.CrossRefGoogle Scholar
  42. 42.
    Nanji AA. Dietary fatty acids: a novel treatment for alcoholic liver disease. Gastroenterology 1995; 109:547–554.PubMedCrossRefGoogle Scholar
  43. 43.
    Mathurin P. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with predniso-lone. Gastroenterology 1996; 110:1847–1853.PubMedCrossRefGoogle Scholar
  44. 44.
    Krom RAF. Liver transplantation and alcohol: who should get transplants. Hepatology 1994;20:28S–32S.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Mark R. Versland

There are no affiliations available

Personalised recommendations